PeterLabs Holdings Bhd (0171) - Cash Flow Conversion Efficiency
Based on the latest financial reports, PeterLabs Holdings Bhd (0171) has a cash flow conversion efficiency ratio of 0.107x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM8.43 Million ≈ $2.12 Million USD) by net assets (RM78.60 Million ≈ $19.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 0171 equity to assets ratio to measure how much of total assets are equity-financed.
PeterLabs Holdings Bhd - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how PeterLabs Holdings Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of PeterLabs Holdings Bhd to evaluate the quality of earnings relative to operating cash generation.
PeterLabs Holdings Bhd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of PeterLabs Holdings Bhd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bharat Road Network Limited
NSE:BRNL
|
-0.109x |
|
Narmada Agrobase Limited
NSE:NARMADA
|
0.002x |
|
Orion Digital Corp.
NASDAQ:ORIO
|
0.051x |
|
Zelan Bhd
KLSE:2283
|
-0.111x |
|
Digicontent Limited
NSE:DGCONTENT
|
0.204x |
|
Gold Pacific Co. Ltd
KQ:038530
|
0.000x |
|
Puma Exploration Inc
V:PUMA
|
-0.007x |
|
Manganese X Energy Corp
V:MN
|
-0.220x |
Annual Cash Flow Conversion Efficiency for PeterLabs Holdings Bhd (2015–2024)
The table below shows the annual cash flow conversion efficiency of PeterLabs Holdings Bhd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see PeterLabs Holdings Bhd (0171) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | RM76.94 Million ≈ $19.32 Million |
RM12.39 Million ≈ $3.11 Million |
0.161x | +125.23% |
| 2023-12-31 | RM75.76 Million ≈ $19.02 Million |
RM5.42 Million ≈ $1.36 Million |
0.071x | +4690.19% |
| 2022-12-31 | RM74.37 Million ≈ $18.67 Million |
RM111.00K ≈ $27.87K |
0.001x | +102.28% |
| 2021-12-31 | RM72.42 Million ≈ $18.18 Million |
RM-4.74 Million ≈ $-1.19 Million |
-0.065x | -139.00% |
| 2020-12-31 | RM58.36 Million ≈ $14.65 Million |
RM9.78 Million ≈ $2.46 Million |
0.168x | -16.76% |
| 2019-12-31 | RM52.47 Million ≈ $13.17 Million |
RM10.57 Million ≈ $2.65 Million |
0.201x | +519.97% |
| 2018-12-31 | RM48.26 Million ≈ $12.12 Million |
RM1.57 Million ≈ $393.66K |
0.032x | -18.48% |
| 2017-12-31 | RM45.74 Million ≈ $11.48 Million |
RM1.82 Million ≈ $457.68K |
0.040x | -81.09% |
| 2016-12-31 | RM39.43 Million ≈ $9.90 Million |
RM8.31 Million ≈ $2.09 Million |
0.211x | +876.31% |
| 2015-12-31 | RM38.99 Million ≈ $9.79 Million |
RM-1.06 Million ≈ $-265.73K |
-0.027x | -- |
About PeterLabs Holdings Bhd
PeterLabs Holdings Berhad, an investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products in Malaysia and internationally. The company operates through three segments: Manufacturing, Trading, and Others. It offers biosecurity products and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceutic… Read more